A broad range of research is conducted in this area, particularly in head-and-neck, breast, ovary, colorectal and haematological cancers, among others. Research in covers a wide range of fields, with disciplines that include nanomedicine, new anticancer agents and predictive molecular markers. Initiatives of specific relevance include the GAIT (Genetic Analysis of Idiopathic Thrombophilia) project, a world pioneer in the identification of genes influencing the risk of thromboembolic disease, and research into antitumour immunotherapy in animals and humans.
